Reassessment of α1-adrenoceptor mechanism in artery contraction: role of ATP and pannexin channels
|Professor James Angusemail@example.com||+ 61 3 834 45896||Personal web page|
The traditional mechanism of sympathetic nerve release of noradrenaline to activate post-junctional a1-adrenoceptors and subsequent vasoconstriction has been challenged. The new hypothesis is that noradrenaline-activated α1-adrenoceptors post-junctionally activate membrane pannexin-1 channels that open to release smooth muscle intracellular ATP that then back-activates in an autacoid manner P2X receptors that cause the contraction of the blood vessel. The evidence to support this pannexin-1 mechanism relied on a non-specific agent use to treat malaria, mefloquine. We have established that mefloquine is a non-specific antagonist with a multitude of actions, that a specific ATP P2X receptor antagonist has no effect on the α1-adrenoceptor mechanism and, therefore, the role for pannexin channels is without foundation in the α1-adrenoceptor cascade of vasoconstriction. The take home message here is that the investigator must be held to account when using pharmacological agents as tools to unravel mechanism that the agent used at that concentration has a unique action. Mefloquine has a wide range of properties at the concentration necessary to block α1-adrenoceptor actions that precluded a unique pannexin-1 antagonism.
Associate Professor Christine E. Wright, BSc Hons, PhD, Laboratory Head
Mr Mark Ross-Smith, BSc Hons, Senior Research Assistant
Mr Ashenafi Betrie, BSc, MSc (Ethiopia), PhD candidate
- Angus JA, Betrie AH, Wright CE. Pannexin-1 channels do not regulate α1-adrenoceptor-mediated vasoconstriction in resistance arteries. Eur J Pharmacol 2015; 750: 43-51.
- Angus JA, Wright CE. ATP is not involved in a1-adrenoceptor-mediated vasoconstriction in resistance arteries. Eur J Pharmacol 2015; 769: 162-166.
School Research Themes
For further information about this research, please contact the research group leader.